Team Publications

2019

  • Goetz D, Kopp BT, Salvator A, Moore-Clingenpeel M, McCoy K, Leung DH, Kloster M, Ramsey BR, Heltshe SH, Borowitz D Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatr Pulmonol 2019 May 54 581-586
  • Hayes D Jr, Kopp BT, Hill CL, Lallier SW, Schwartz CM, Tadesse M, Alsudayri A, Reynolds SD Cell Therapy for Cystic Fibrosis Lung Disease: Regenerative Basal Cell Amplification. Stem Cells Transl Med 2019 Mar 8 225-235
  • Ruda JM, Payne L, May A, Splaingard M, Lemle S, Jatana KR Improving Communication Delay of Outpatient Sleep Study Results to Pediatric Otolaryngology Patients and Families. Otolaryngol Head Neck Surg 2019 May 160 791-798
  • Ruhl AP, Sadreameli SC, Allen JL, Bennett DP, Campbell AD, Coates TD, Diallo DA, Field JJ, Fiorino EK, Gladwin MT, Glassberg JA, Gordeuk VR, Graham LM, Greenough A, Howard J, Kato GJ, Knight-Madden J, Kopp BT, Koumbourlis AC, Lanzkron SM, Liem RI, Machado RF, Mehari A, Morris CR, Ogunlesi FO, Rosen CL, Smith-Whitley K, Tauber D, Terry N, Thein SL, Vichinsky E, Weir NA, Cohen RT, Klings ES Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc 2019 Sep 16 e17-e32

2018

  • Gushue C, Miller R, Sheikh S, Allen ED, Tobias JD, Hayes D Jr, Tumin D Gaps in health insurance coverage and emergency department use among children with asthma. J Asthma 2018 Oct 26 1-9
  • Kirkby S, Rossetti A, Hayes D Jr, Allen E, Sheikh S, Kopp B, Patel A Benefits of pulmonary rehabilitation in pediatric asthma. Pediatr Pulmonol 2018 May 7
  • Ruoff C, Pizza F, Trotti LM, Sonka K, Vandi S, Cheung J, Pinto S, Einen M, Simakajornboon N, Han F, Peppard P, Nevsimalova S, Plazzi G, Rye D, Mignot E The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study. J Clin Sleep Med 2018 Jan 15 14 65-74
  • Zhang S, Shrestha CL, Kopp BT Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function. Sci Rep 2018 Nov 20 8 17066

Show More